What is MANH's health score?

MANHATTAN ASSOCIATES INC (MANH) has a TradeApes health score of 65 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is MANH's estimated fair value?

Based on our 5-year discounted cash flow model, MANHATTAN ASSOCIATES INC's estimated fair value is $81.07 per share, representing a -46.2% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is MANH undervalued or overvalued?

Our model currently rates MANH as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for MANH... Refresh in a moment for the full analysis.

MANHATTAN ASSOCIATES INC (MANH)

Technology Overvalued medium healthy

$150.58

Updated: 2026-06-05

TradeApes Score

Financial Strength

75 Strong

Operating Trend

70 Healthy

Relative Value

60 Healthy

Capital Allocation

40 Weak

Risk

80 Strong

Est. Fair Value $81.07

DCF Upside -46.2%

Sector Rank #1342 of 7815

Key Findings

+ Historically cheap — EV/EBITDA in bottom 25% of its 5-year range

Unlock Full Report →

− High P/E — 25–45×, growth premium already priced in

Unlock Full Report →

2 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.